Nafld, Nash
Miyake, T.; Onji, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 5): 528-532
2012
ISSN/ISBN: 0047-1852 PMID: 23156452 Document Number: 659106
Document emailed within 1 workday
Related Documents
James, O.F.W. 2002: NASH/NAFLD management Acta Gastro-Enterologica Belgica 65(4): 200-203Aoyama, T.; Watanabe, S. 2016: Liver disease (NAFLD, NASH) Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 460-464
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Tanaka, N.; Aoyama, T. 2006: PPAR and NASH Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1089-1094
Tokushige, K. 2009: Diagnosis and therapy in NASH Rinsho Byori. Japanese Journal of Clinical Pathology 57(9): 848-853
Fagoonee, S.; Pellicano, R. 2014: Vitamin D and NAFLD: the need for interventional trials Minerva Medica 105(3): 261
Hagström, H.; Hoffstedt, J.; Reynisdottir, S. 2017: New guidelines for NAFLD – a Swedish perspective Lakartidningen 114
Rastamanesh, R.; Catanzaro, R.; Sollano, Jè.; Marotta, F. 2014: NAFLD: a sign of "early aging"? Acta Bio-Medica: Atenei Parmensis 84(3): 244-245
Reyes, Rúl.Bernal. 2006: NAFLD and metabolic syndrome a troublesome association Revista de Gastroenterologia de Mexico 71(4): 510-511
Morita, Y.; Ueno, T.; Sasaki, N.; Tateishi, Y.; Nagata, E.; Kage, M.; Sata, M. 2005: Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes Hepato-Gastroenterology 52(65): 1338-1343
Joyner, D. 2004: Nash County Emergency Services offers Explorer program Emergency Medical Services 33(7): 67
P, S.; Nh, R. 2020: Study of Correlation between Carotid Intimalthickness and Insulin Resistance in Patients with NAFLD Journal of the Association of Physicians of India 68(1): 88
Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681
Lazarus, J.V.; Mark, H.E.; Colombo, M.; Demaio, S.; Dillon, J.F.; George, J.; Hagström, H.; Hocking, S.; Lee, N.; Nieuwenhuijsen, M.J.; Rinella, M.E.; Romero-Gomez, M.; Soriano, J.B.; Schattenberg, J.ör.M.; Tacke, F.; Tsochatzis, E.A.; Valenti, L.; Zelber-Sagi, S.; Ashworth Dirac, M.; Huang, T.T.-K. 2022: A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach Alimentary Pharmacology and Therapeutics 55(2): 234-243
Lesmana, C.R.; Lesmana, L.A.; Akbar, N.; Gani, R.A.; Simandjuntak, W.; Oemardi, M.; Soejono, C.H.; Marwoto, W.; Juwono, V. 2009: Clinical picture, insulin resistance, and adipocytokines profiles of nonalcoholic steatohepatitis (NASH) patients in Indonesia Acta Medica Indonesiana 41(1): 6-10